Using cone and plate(let) analyzer to predict bleeding in cardiac surgery

Asian Cardiovascular and Thoracic Annals

Volumn 14, Issue 4, 2006, Pages 310-315

  Gerrah, Rabin ^a   Brill, Alex ^b   Tshori, Sagi ^b   Lubetsky, Aharon ^c   Merin, Gideon ^b   Varon, David ^b  

^a ASSUTA MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYZER; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTRACELLULAR MATRIX; FUNCTION TEST; HEART SURGERY; HUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PREDICTION; RISK FACTOR; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 33747353291     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230601400409     Document Type: Article

References (20)

1. Weerasinghe A, Taylor KM The platelet in cardiopulmonary bypass. Ann Thorac Surg 1998;66:2145-52.
2. Zilla P, Fasol R, Deutsch M, Laufer G, Wollenek G, Muller MM, et al. Whole blood aggregometry and platelet adenine nucleotides during cardiac surgery. Scand J Thorac Cardiovasc Surg 1988;22:165-9.
3. Wan S, LeClere JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997;112:676-92.
4. Collman RW. Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 1990;49:32-4.
5. Varon D, Dardik R, Shenkman S, Kotev-Emeth S, Farzame N, Tamarin I, et al. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997;85:283-94.
6. Shenkman B, Savion N, Dardik R, Tamarin I, Varon D. Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor. Thromb Res 2000;99:353-61.
7. Knobler H, Savion N, Shenkman B, Kotev-Emeth S, Varon D. Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients. Thromb Res 1998;90:181-90.
8. Shenkman B, Linder N, Savion N, Tamarin I, Dardik R, Kennet G, et al. Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von Willebrand factor. Pediatr Res 1999;45:270-5.
9. Wang X, Dorsam RT, Lauver A, Wang H, Barbera FA, Gibbs S, et al. Comparative analysis of various platelet glycoprotein IIb/IIIa antagonists on shear-induced platelet activation and adhesion. J Pharmacol Exp Ther 2002;303:1114-20.
10. Kenet G, Lubetsky A, Shenkman B, Tamarin I, Dardik R, Rechavi G, et al. Cone and platelet analyser (CPA): a now test for the prediction of bleeding among thrombocytopenic patients. Br J Haematol 1998;101:255-9.
11. Varon D, Lashevski I, Brenner B, Beyar R, Lanir N, Tamarin I, et al. Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions. Am Heart J 1998;135(5 Pt 2 Su):S187-93.
12. Shenkman B, Schneiderman J, Tamarin I, Kotev-Emeth S, Savion N, Varon D. Testing the effect of GPIIb-IIIa antagonist in patients undergoing carotid stenting: correlation between standard aggregometry, flow cytometry and the cone and plate(let) analyzer (CPA) methods. Thromb Res 2001;102:311-7.
13. Chiba Y, Morioka K, Muraoka R, Ihaya A, Kimura T, Uesaka T, et al. Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass. Ann Thorac Surg 1998;65:107-14.
14. Wahba A, Black G, Koksch M, Rothe G, Preuner J, Schmitz G, et al. Cardiopulmonary bypass leads to a preferential loss of activated platelets. A flow cytometric assay of platelet surface antigens. Eur J Cardiothorac Surg 1996;10:768-73.
15. Hyde JA, Chinn JA, Graham TR. Platelets and cardiopulmonary bypass. Perfusion 1998;13:389-407.
16. Kvarstein B, Vaage S, Tjonneland S, Cappelen C Jr, Aune H. The adhesiveness of blood platelets before, during and after cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 1977;11:57-9.
17. Kunitomo R, Tsurusaki S, Suzuki R, Takaji K, Moriyama S, Hagio K, et al. Predictive factors for platelet number after cardiopulmonary bypass and postoperative blood loss. ASAIO J 2002;48:671-4.
18. Levy JH, Smith PK. Platelet inhibitors and cardiac surgery. Ann Thorac Surg 2000;70(2 Suppl):S1-2.
19. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 1999;91:1122-51.
20. Coller BS. Monitoring platelet GP IIb/IIIa antagonist therapy. Circulation 1998;97:5-9.